Exer AI
PrivateLast Round
Series A
Nov 8, 2022
Total Funding Raised
$11M
Company Overview
Exer AI operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was a Series A round in November 2022.
Exer AI is a healthcare technology company that provides a clinical AI platform using computer vision for motion assessments without the need for sensors or wearables.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Computer Vision, Telemedicine, EHR & EMR, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exer AI Comparables
Compare Exer AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MotionArc | 83% | |
| EuMotus | 81% | |
| MobilityZ Health | 78% |
For institutional investors. Book with your work email.
Exer AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 8, 2022 | ||||
| Seed | Oct 8, 2020 | ||||
| Seed | May 29, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Exer AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Service Provider Capital | Seed |
| Morado Ventures | Seed |
| Backstage Capital | Series A |
| Sand Hill Angels | Series A |
| Shatter Fund | Seed |
| Range Ventures | Seed |
| AME Cloud Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2022
$6.5M round led by Sand Hill Angels
- Oct 8, 2020
$2M raised from AME Cloud Ventures, GGV Capital, and others.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 11, 2026
Exer Labs, Inc introduces the Exer Scan app, including its hand/wrist module, at Mayo Clinic in Minnesota on Aug 11th '26 to support musculoskeletal care delivery and clinical documentation workflows.
For institutional investors. Book with your work email.
Exer AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Exer AI's valuation, stock price, and market status.
Is Exer AI a public or private company?
Exer AI is a private company.
What is the current stock price of Exer AI?
Exer AI is a private company, so its shares have no public market price. Caplight tracks Exer AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exer AI worth (valuation)?
Valuation information for Exer AI is not publicly available.
Can I buy Exer AI stock?
Exer AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exer AI's last funding round?
Exer AI's most recent funding round was Series A on November 8, 2022.
Who are the main investors in Exer AI?
Key investors in Exer AI include Sand Hill Angels, Signia Venture Partners.
Will Exer AI IPO soon?
No public IPO plans have been announced for Exer AI.
How can I track Exer AI secondary market activity?
Caplight tracks bids, offers, and trades in Exer AI's shares on secondary markets.